3D-QSAR引导的分子设计和蛋白质 - 连接体相互作用研究,以发现糖酸脱酶抑制剂
Kun Li1,2, Jia Li1,2, Zhenwu Yu1,2,3
1State Key Laboratory of Elemento-Organic Chemistry, College of Chemistry, Nankai University, Tianjin 300071, P. R. China.
Journal of agricultural and food chemistry
|June 16, 2025
概括
研究人员开发了针对酸脱酶 (SDH) 的新型pyrazole化合物,用于抗真菌应用. 化合物B5在与fluxapyroxad相比,对Rhizoctonia solani表现出更高的疗效,这表明它是一个有前途的新型杀菌剂候选者.
科学领域:
- 农业科学 农业科学
- 药用化学 医学化学
- 生物化学 生物化学
背景情况:
- 酸脱酶 (SDH) 是抗真菌药物开发的验证目标.
- 现有的SDH抑制剂对于管理农业中的真菌病至关重要.
- 持续需要新型杀菌剂,其疗效和安全性有所提高.
研究的目的:
- 设计和合成针对SDH的新型含皮拉化合物.
- 评估设计化合物的抗真菌活性,以对抗Rhizoctonia solani.
- 阐明强效化合物的作用模式和结合相互作用.
主要方法:
- 建立了一个三维定量结构-活动关系 (3D-QSAR) 模型.
- 合成了一系列基于pyrazole的化合物.
- 进行生物测试,酶活性测试,转录基因分析,分子对接和分子动力学模拟.
主要成果:
- 化合物B5对R. solani表现出强烈的活性 (EC50 = 0.002 μg/mL),表现优于fluxapyroxad.
- 在酶测定中,B5显示了较低的IC50值 (0.12μM) 与fluxapyroxad (0.35μM) 相比.
- 在体内B5的杀菌活性 (94.44%) 与fluxapyroxad (88.89%) 相当,它准三碳酸循环.
结论:
- 化合物B5是新型SDH抑制剂杀菌剂的高效化合物.
- 该研究强调了pyrazole衍生物作为强效抗真菌剂的潜力.
- 由于B5的独特结构和强大活动,需要进一步研究农业应用.
关键词:
3D-QSAR 是一个3D-QSAR.这种植物是Rhizoctonia solani.SDH SDH SDH SDH SDH SDH SDH SDH SDH SDH SDH SDH SDH SDH SDH SDH SDH设计和合成它们.杀菌剂是一种杀菌剂.更多相关视频
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
388
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
546
相关概念视频
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Ligand Binding Sites
13.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.6K
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
